Complete elimination is a difficult goal for trachoma programs in severely affected communities

Clinical Infectious Diseases

Volumn 46, Issue 4, 2008, Pages 564-566

  Gill, Deborah A ^a,b   Lakew, Takele ^c   Alemayehu, Wondu ^c   Melese, Muluken ^c   Zhou, Zhaoxia ^a   House, Jenafir I ^a   Hong, Kevin C ^a   Ray, Kathryn J ^a   Gandhi, Nandini ^a   Whitcher, John P ^a,b   Gaynor, Bruce D ^a,b   Lietman, Thomas M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ORBIS INTERNATIONAL   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; COMMUNITY; CONJUNCTIVAL BIOPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TRACHOMA; ADOLESCENT; CHILD; ETHIOPIA; INFANT; INFECTION CONTROL; METHODOLOGY; MIDDLE AGED; RURAL POPULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; ETHIOPIA; FEMALE; HUMANS; INFANT; INFECTION CONTROL; MALE; MIDDLE AGED; RURAL POPULATION; TETRACYCLINE; TRACHOMA;

EID: 38849138737     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/526777     Document Type: Article

References (13)

1. Mariotti SP. New steps toward eliminating blinding trachoma. N Engl J Med 2004; 351:2004-7.
2. Emerson PM, Cairncross S, Bailey RL, Mabey DC. Review of the evidence base for the "F" and "E" components of the SAFE strategy for trachoma control. Trop Med Int Health 2000; 5:515-27.
3. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Med 1999; 5:572-6.
4. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 2004; 292:721-5.
5. Gaynor BD, Miao Y, Cevallos V, et al. Eliminating trachoma in areas with limited disease. Emerg Infect Dis 2003; 9:596-8.
6. Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005; 365:1321-8.
7. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351:1962-71.
8. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006; 295:1142-6.
9. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366:1296-300.
10. Bailey RL, Hayes L, Pickett M, Whittle HC, Ward ME, Mabey DC. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol 1994; 78:813-7.
11. Yang JL, Schachter J, Moncada J, et al. Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol 2007; 91:293-5.
12. Ray KJ, Porco TC, Hong KC, et al. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis 2007; 7:91.
13. Lee DC, Chidambaram JD, Porco TC, Lietman TM. Seasonal effects in the elimination of trachoma. Am J Trop Med Hyg 2005; 72:468-70.